As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the week. Topics ...

Lipid-lowering therapy can be considered with a 10-year PREVENT-ASCVD risk estimate of 3% to <5% (borderline) and should be considered for those at 5% to <10% (intermediate) 10-year risk. For ...

Economist worries about healthcare cost growth began when national health spending topped 6% of gross domestic product (GDP) in 1970. President Nixon persuaded Congress to pass the Health Maintenance ...

Nevada regulators have fined three people who played a role in offering peptide injections last year at a Las Vegas anti-aging conference where two women became critically ill following treatment.

The Environmental Protection Agency (EPA) proposed Friday to weaken air pollution limits on a chemical used to sterilize medical equipment, a move that would reverse a Biden administration finding of ...

Doctors in all specialties need more education on menopause and hormone therapy so that they don't give women conflicting recommendations, several speakers said here Friday at the HHS National ...

An Arizona physician group will pay $4.75 million to resolve allegations that doctors violated the False Claims Act by ...

The selective estrogen receptor degrader giredestrant plus palbociclib (Ibrance) did not significantly improve progression-free survival (PFS) in advanced hormone receptor-positive/HER2-negative ...

CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how clinicians can communicate effectively and empathetically with patients navigating a chronic ...

Microplastics were detected in prostate tissue from nearly all patients undergoing prostate cancer surgery in a small proof-of-concept study presented at the American Society of Clinical Oncology ...

Kennedy Jr. is fielding pressure from the White House to relax his controversial approach to vaccine policies as the midterms near, but his most steadfast supporters are pressing for more aggressive ...